NCT06479811
- Conditions
- Carcinoma, Cranial Nerve Diseases, Esthesioneuroblastoma, +43 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Urologic Neoplasms
Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.
2,952 public trials
630 recruiting studies
Urologic Neoplasms trial results
NCT07383441
- Conditions
- Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +18 more
- Locations
-
- Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
- Highlands Oncology Group - Rogers Rogers, Arkansas, United States
- Highlands Oncology Group Springdale, Arkansas, United States
NCT07144319
- Conditions
- Bladder Cancer, Carcinoma, Female Urogenital Diseases, +14 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Regents of the University of Michigan Ann Arbor, Michigan, United States
- Rutgers Cancer Institute New Brunswick, New Jersey, United States
- Oslo University Hospital Oslo, Norway
NCT06960577
- Conditions
- Cisplatin, Doxorubicin, Female Urogenital Diseases, +14 more
- Locations
-
- Research Site Chermside, Australia
- Research Site Elizabeth Vale, Australia
- Research Site Heidelberg, Australia
- Research Site Hong Kong, Australia
NCT05433142
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +28 more
- Locations
-
- Xencor Investigative Site Phoenix, Arizona, United States
- Xencor Investigative Site Duarte, California, United States
- Xencor Investigative Site Sacramento, California, United States
- Xencor Investigative Site New Haven, Connecticut, United States
Recruiting
DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr
NCT04106115
- Conditions
- Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
- Locations
-
- Cambridge University NHS FT Cambridge, United Kingdom
- Guy's and St Thomas' NHS Foundation Trust London, United Kingdom
- Royal Free London NHS FT London, United Kingdom
- The Royal Marsden NHS Foundation Trust London, United Kingdom
Recruiting
Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer
NCT07226544
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT07517198
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Diseases, +66 more
- Locations
-
- Start Lacn Los Angeles, California, United States
- START Dallas Fort Worth, Texas, United States
- START Mountain Region West Valley City, Utah, United States
NCT05403177
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +67 more
- Locations
-
- Kingston Health Sciences Centre Kingston, Ontario, Canada
- Ottawa Health Research Institute Ottawa, Ontario, Canada
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT06265285
- Conditions
- Adenocarcinoma, Advanced Esophageal Squamous Cell Carcinoma, Advanced Renal Cell Carcinoma, +81 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States